Source:http://linkedlifedata.com/resource/pubmed/id/16788210
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2006-8-22
|
pubmed:abstractText |
Increased plasma concentrations of apolipoprotein A-IV (apoA-IV) in chronic renal disease suggest a metabolic role of the kidney for this antiatherogenic protein. Therefore, we investigated patients with various forms of proteinuria and found increased serum concentrations of apoA-IV in 124 nephrotic patients compared with 274 controls (mean 21.9 +/- 9.6 vs. 14.4 +/- 4.0 mg/dl; P < 0.001). Decreasing creatinine clearance showed a strong association with increasing apoA-IV levels. However, serum albumin levels significantly modulated apoA-IV levels in patients with low creatinine clearance, resulting in lower levels of apoA-IV in patients with low compared with high albumin levels (21.4 +/- 8.6 vs. 29.2 +/- 8.4 mg/dl; P = 0.0007). Furthermore, we investigated urinary apoA-IV levels in an additional 66 patients with a wide variety of proteinuria and 30 controls. Especially patients with a tubular type of proteinuria had significantly higher amounts of apoA-IV in urine than those with a pure glomerular type of proteinuria and controls (median 45, 14, and 0.6 ng/mg creatinine, respectively). We confirmed these results in affected members of a family with Dent's disease, who are characterized by an inherited protein reabsorption defect of the proximal tubular system. In summary, our data demonstrate that the increase of apoA-IV caused by renal impairment is significantly modulated by low levels of serum albumin as a measure for the severity of the nephrotic syndrome. From this investigation of apoA-IV in urine as well as earlier immunohistochemical studies, we conclude that apoA-IV is filtered through the normal glomerulus and is subsequently reabsorbed mainly by proximal tubular cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-2275
|
pubmed:author |
pubmed-author:DieplingerHansH,
pubmed-author:HeidIris MIM,
pubmed-author:KönigPaulP,
pubmed-author:KronenbergFlorianF,
pubmed-author:KronenbergMartina FMF,
pubmed-author:LhottaKarlK,
pubmed-author:LingenhelArnoA,
pubmed-author:NeyerUlrichU,
pubmed-author:RantnerBarbaraB,
pubmed-author:SchoberMariaM,
pubmed-author:von EckardsteinArnoldA
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2071-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16788210-Adult,
pubmed-meshheading:16788210-Aged,
pubmed-meshheading:16788210-Apolipoproteins A,
pubmed-meshheading:16788210-Creatinine,
pubmed-meshheading:16788210-Female,
pubmed-meshheading:16788210-Humans,
pubmed-meshheading:16788210-Hyperlipidemias,
pubmed-meshheading:16788210-Kidney,
pubmed-meshheading:16788210-Kidney Diseases,
pubmed-meshheading:16788210-Linear Models,
pubmed-meshheading:16788210-Male,
pubmed-meshheading:16788210-Middle Aged,
pubmed-meshheading:16788210-Nephrotic Syndrome,
pubmed-meshheading:16788210-Proteinuria,
pubmed-meshheading:16788210-Serum Albumin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
|
pubmed:affiliation |
Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|